Laddar...
Safety and immunotoxicity assessment of immunomodulatory monoclonal antibodies
Most therapeutic monoclonal antibodies (mAbs) licensed for human use or in clinical development are indicated for treatment of patients with cancer and inflammatory/autoimmune disease and as such, are designed to directly interact with the immune system. A major hurdle for the development and early...
Sparad:
| Huvudupphovsmän: | , , , , , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Landes Bioscience
2010
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2881251/ https://ncbi.nlm.nih.gov/pubmed/20421713 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|